Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors: Comparing Trial and Real World Use (Study Protocol)

Overview of attention for article published in Diabetes Therapy, January 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#24 of 1,034)
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news: 4 news outlets
blogs: 1 blog

twitter: 2 X users

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 40 Mendeley

Summary News Blogs X Dimensions citations

So far, Altmetric has seen 1 blog post.

Diabetes Drug Trial Needs to Widen Participants to Understand Full Impact of Drugs

Pharmaceutical Processing, 14 Jun 2017

NewsMore work needs to be done to examine the real world effects of the commonly prescribed diabetes drug empagliflozin, new…